PepGen (PEPG) Change in Acquisitions & Divestments (2024 - 2026)
PepGen (PEPG) posted Change in Acquisitions & Divestments of $27.0 million for Q1 2026, up 28.57% sequentially from $21.0 million in Q4 2025, and up 12.5% YoY from $24.0 million in Q1 2025.
Analysis
PepGen (PEPG) Change in Acquisitions & Divestments (2024 - 2026) Analysis & Trends
PepGen has reported Change in Acquisitions & Divestments for 3 years, with the latest figure at $27.0 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments rose 12.5% year-over-year to $27.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $82.0 million (down 28.07% YoY) and the FY2025 annual result came in at $79.0 million, down 26.85% from the prior year.
- Change in Acquisitions & Divestments improved to $27.0 million in Q1 2026 per PEPG's latest filing, from $21.0 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $48.0 million in Q4 2024 and troughed at $12.0 million in Q2 2024.
- A 3-year average of $23.8 million and a median of $21.0 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
- The widest YoY moves for Change in Acquisitions & Divestments: up 33.33% in 2025, down 56.25% in 2025.
- Over 3 years, Change in Acquisitions & Divestments stood at $48.0 million in 2024, then tumbled by 56.25% to $21.0 million in 2025, then gained by 28.57% to $27.0 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $27.0 million, $21.0 million, and $19.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | PepGen | 217.99 Mn | 217.99 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.00 Mn |
| Mar 31, 2026 | 27.00 Mn |
| Dec 31, 2025 | 21.00 Mn |
| Sep 30, 2025 | 19.00 Mn |
| Jun 30, 2025 | 15.00 Mn |
| Mar 31, 2025 | 24.00 Mn |
| Dec 31, 2024 | 48.00 Mn |
| Sep 30, 2024 | 30.00 Mn |
| Jun 30, 2024 | 12.00 Mn |
| Mar 31, 2024 | 18.00 Mn |